SARS funding granted in HK, but insufficient in the US

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.414, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Funding to support SARS granted in HK, but insufficient in the US

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US National Institute of Allergies and Infectious Diseases has granted $US10 million in funding to pharmaceutical company Baxter Healthcare to develop a vaccine against the coronavirus causing severe acute respiratory syndrome

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US orphan drug designation granted for MGCD0103

By  

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

ARC 1779 granted orphan status for TTP in the US.

By  

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

US health research funding slows

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite